In March 2025, the company announced new programs for the direct-to-customer featuring of its Wegovy weight loss drug. The company established a fresh pharmacy, identified as NovoCare, which might cost consumers $499 per 30 days for entry to the drug, fewer than half the cost of the drug as a result of other pharmaceutical distribution networks.[fi